The first is titled “Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma” (Lee et al., 2020), showing that the fusion gene of CCDC32-CBX3 exists in 10 % of neuroblastoma patients. Here, CBX3 is linked to neuroblastoma.